CBCD Questions EU’s Advice on HPV Vaccination

Sept. 10, 2012 - PRLog -- The Center for the Biology of Chronic Disease (CBCD) has just learned that the European Centre for Disease Prevention and Control (ECDC), according to a story in Reuters, has said that “while 19 out of 29 countries in the region had introduced HPV vaccine programs, vaccination rates were as low as 17 percent in some.”

Marc Sprenger, the ECDC’s director said, “We public health authorities, frontline healthcare workers and parents alike have a shared responsibility to protect thousands of women from cervical cancer.

The CBCD is in agreement. It is the public health authority’s responsibility to help prevent HPV infections. However, the CBCD questions whether the HPV Vaccine is the best method used to protect the public from the virus that can cause some forms of cancer as well as genital warts.

British drugmaker GlaxoSmithKline (GSK) and the U.S.’s Merck & Co make the only two HPV vaccines licensed for use in the U.K.

Merck’s Gardasil is designed to help prevent four strains of HPV – two responsible for cervical cancer and two that cause genital warts – while Cervarix, made by GSK, targets only the two cancer strains.

The problem the CBCD sees is that the HPV vaccine only protects against four strains yet, there are 150 other types of HPVs, at least 15 of which can cause cancer, and Gardasil provides no protection against these other strains. [1][2]

Moreover, Merck’s own studies show that the vaccine is only effective for 5 years. Thus, if your 11 year old daughter gets the vaccine, it will have stopped working by the time she is 16…right when she is actually at the highest risk for acquiring an HPV infection. [3]

Finally, the HPV vaccine does nothing for those who already have an HPV infection. It will not get rid of genital warts, and if someone already is experiencing abnormal cervical cells due to HPV…the vaccine simply does nothing for that person.

This information is particularly important in light of the fact that there are no approved treatments that actually kill the virus.

A healthy immune system is a person’s best defense against HPV caused diseases.

The good news is that the U.S.’s CDC says, “In 90% of cases, the body’s immune system clears HPV naturally within two years.”

However, clearing the virus does not mean the virus leaves the body for good. It just means that your immune system is powerful enough to prevent the virus from causing a disease. The virus itself understands this and establishes itself in one of the body’s organs in what scientists call a latent infection. When a virus is latent, it acts like it is asleep. Non-scientists would say that it is dormant. A weakened immune system, however, allows the HPV virus to “wake up” and become active again.

That’s why the CBCD would like to call attention to an HPV remedy that boosts the immune system and helps target the latent HPV virus that causes genital warts and some kinds of cancer.

“The key to your health is to reduce the level of the chronic viruses in your body to harmless levels.” – Dr. Hanan Polansky

The name of that HPV remedy is Gene-Eden-VIR. This scientifically designed, all natural product helps your own body maintain low concentrations of the latent, (sleeping) Human Papillomavirus.

By helping your own body’s immune system to keep the numbers of latent HPV virus down, you are also lowering your risk of developing genital warts and some forms of cancer.

That’s why Gene-Eden-VIR is so important!

You may have questions about the efficacy, safety, and cost of Gene-Eden-VIR. These are great, easily answered questions.

Gene-Eden-VIR is highly effective against the latent Human Papillomavirus; each ingredient was chosen through a scientific approach. PolyDNA scientists scanned thousands of scientific and medical papers published in various medical and scientific journals around the world in order to identify the safest, most effective natural ingredients that target the latent (sleeping)HPV Virus.

Gene-Eden-VIR is incredibly safe. There are no reports of side effects, and it has been on the market for over three years. Each capsule contains a patented formula of five all natural ingredients including selenium, camellia sinesis extract, quercetin, cinnamomum extract, and licorice extract. In addition, each bottle is GMP Certified.

People can easily access these scientific papers on the ingredients of Gene-Eden-VIR on pubmed.gov.

Gene-Eden-VIR is sold online through the Gene-Eden website. This lowers operating costs and allows savings to be delivered to polyDNA’s valued customers! Each bottle of Gene-Eden-VIR (a one month’s supply) costs just $34.99. Moreover, ordering Gene-Eden-VIR is completely secure and confidential. http://www.gene-eden-kill-virus.com.

Visit now to order!

To learn more about Gene-Eden-VIR, the only product on the market today that helps the body maintain low numbers of the latent Human Papillomavirus (HPV) and that is scientifically backed by published material, visit http://www.gene-eden-kill-virus.com or call our American line at: 585-250-9999.

References:

[1] Human Papillomaviruses and Cancer, National Cancer Institute, September 7, 2011, http://www.cancer.gov/cancertopics/factsheet/Risk/HPV/print

[2] Haug CJ, Human Papillomavirus Vaccination – Reasons for Caution, New England Journal of Medicine, August 21, 2008, 359; 861-862.

[3] Tomljenovic L and Shaw CA, Human Papillomavirus (HPV) Vaccine Policy and Evidence-Based Medicine: Are They at Odds? Annals of Medicine December 22, 2011; http://informahealthcare.com/doi/abs/10.3109/07853890.201...


The Center for the Biology of Chronic Disease is a research center recognized by the IRS as a 501(c)(3) non-for-profit organization. The mission of the CBCD is to advance the research on the biology of chronic diseases, and to accelerate the discovery of treatments for these diseases.

The CBCD published the “Purple” book entitled “Microcompetition with Foreign DNA and the Origin of Chronic Disease” written by Dr. Hanan Polansky. The book presents Dr. Polansky’s highly acclaimed scientific theory on the relationship between the DNA of latent (chronic) viruses and the onset of chronic diseases.